Contact Person : Taryn ODonnell; Last Date for the submission of abstract : Not Available ; Description : Every new formulation and generic drug needs to demonstrate bioequivalence to secure market approval. But each of these required tests can be complicated by innovations in drug delivery or dosing features, yielding unpredictable challenges.